David Larsen
Stock Analyst at BTIG
(0.18)
# 4,644
Out of 5,044 analysts
586
Total ratings
34.7%
Success rate
-4.6%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCGO DocGo | Reiterated: Hold | n/a | $0.3382 | - | 20 | Sep 30, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $25 | $17.35 | +44.09% | 33 | Sep 18, 2026 | |
| OMDA Omada Health | Rated: Buy | $35 | $21.55 | +62.41% | 3 | Sep 11, 2026 | |
| DH Definitive Healthcare | Rated: Hold | n/a | $0.98 | - | 10 | Sep 3, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $115 | $92.61 | +24.18% | 32 | Aug 28, 2026 | |
| MDLN Medline | Reiterated: Buy | $55 | $36.26 | +51.68% | 8 | Aug 27, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $340 | $296.13 | +14.81% | 14 | Aug 26, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | n/a | $1.77 | - | 26 | Aug 19, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $100 → $110 | $84.01 | +30.94% | 16 | Aug 19, 2026 | |
| LFST LifeStance Health Group | Reiterated: Buy | $16 → $18 | $12.42 | +44.93% | 8 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $30.92 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $36.71 | +36.20% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $37.55 | +73.10% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.85 | +67.87% | 16 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $9 | $2.63 | +242.21% | 44 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.70 | - | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $63.74 | +41.20% | 19 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.77 | - | 20 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $40 | $27.93 | +43.22% | 19 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $4.04 | +98.02% | 51 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $6.63 | +35.75% | 12 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $30.50 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $35.82 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $259.88 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.95 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $82.39 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $323.85 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $301.79 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $86.16 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $237.57 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $9 | $0.428 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $938.84 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $5.09 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
DocGo
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3382
Upside: -
Cryoport
Sep 18, 2026
Reiterated: Buy
Price Target: $25
Current: $17.35
Upside: +44.09%
Omada Health
Sep 11, 2026
Rated: Buy
Price Target: $35
Current: $21.55
Upside: +62.41%
Definitive Healthcare
Sep 3, 2026
Rated: Hold
Price Target: n/a
Current: $0.98
Upside: -
HealthEquity
Aug 28, 2026
Reiterated: Buy
Price Target: $115
Current: $92.61
Upside: +24.18%
Medline
Aug 27, 2026
Reiterated: Buy
Price Target: $55
Current: $36.26
Upside: +51.68%
Veeva Systems
Aug 26, 2026
Reiterated: Buy
Price Target: $340
Current: $296.13
Upside: +14.81%
Health Catalyst
Aug 19, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.77
Upside: -
Henry Schein
Aug 19, 2026
Reiterated: Buy
Price Target: $100 → $110
Current: $84.01
Upside: +30.94%
LifeStance Health Group
Aug 19, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $12.42
Upside: +44.93%
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $30.92
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $36.71
Upside: +36.20%
Aug 9, 2026
Reiterated: Buy
Price Target: $65
Current: $37.55
Upside: +73.10%
Aug 9, 2026
Reiterated: Buy
Price Target: $35
Current: $20.85
Upside: +67.87%
Aug 6, 2026
Rated: Buy
Price Target: $10 → $9
Current: $2.63
Upside: +242.21%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.70
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: $90
Current: $63.74
Upside: +41.20%
Jul 29, 2026
Rated: Hold
Price Target: n/a
Current: $5.77
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $30 → $40
Current: $27.93
Upside: +43.22%
Jul 16, 2026
Rated: Buy
Price Target: $8
Current: $4.04
Upside: +98.02%
Jul 15, 2026
Reiterated: Buy
Price Target: $9
Current: $6.63
Upside: +35.75%
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $30.50
Upside: -
Apr 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $35.82
Upside: -
Feb 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $259.88
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $4.95
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $82.39
Upside: -
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $323.85
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $301.79
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $86.16
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $237.57
Upside: n/a
Oct 31, 2018
Reiterated: Hold
Price Target: $17 → $9
Current: $0.428
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $938.84
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $5.09
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a